Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.3389/fmicb.2017.01057 https://repositorio.unifesp.br/handle/11600/53657 |
Resumo: | Paracoccidioidomycosis (PCM) is an endemic systemic mycosis in Latin America, with the highest prevalence in Brazil, Colombia, and Venezuela. Fungi of the Paracoccidioides genus are etiologic agents of the disease. The 15 amino acid peptide P10 is derived from gp43, the main diagnostic antigen of Paracoccidioides brasiliensis. We previously reported that P10-pulsed dendritic cells (DCs) induce a protective response against P. brasiliensis. Presently, dexamethasone-treated BALB/c mice were intratracheally infected with P. brasiliensis Pb18 to establish the therapeutic efficacy of P10-pulsed DCs. Immunosuppressed and infected animals that received DCs had a reduction in their fungal burden, and this result was most pronounced in mice receiving DCs primed with P10. The efficacy of therapeutic DCs was significantly augmented by concomitant treatment with trimethoprim-sulfamethoxazole. Additionally, primedDCs with or without the antifungal drug induced a beneficial Th1-biased immune response and significantly reduced tissue damage. In conclusion, these studies with immunocompromised mice demonstrate that P10-pulsed DCs with or without concomitant antifungal drugs are potently effective in combating invasive PCM. These findings support further translational studies to validate the use of P10-primed DCs for PCM in immunocompetent and immunosuppressed hosts. |
id |
UFSP_a0faab0b46ab028394a4a4d1cb1ee89e |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/53657 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with ParacoccidioidomycosisParacoccidioides brasiliensisparacoccidioidomycosisP10adjuvantsdendritic cellsvaccineParacoccidioidomycosis (PCM) is an endemic systemic mycosis in Latin America, with the highest prevalence in Brazil, Colombia, and Venezuela. Fungi of the Paracoccidioides genus are etiologic agents of the disease. The 15 amino acid peptide P10 is derived from gp43, the main diagnostic antigen of Paracoccidioides brasiliensis. We previously reported that P10-pulsed dendritic cells (DCs) induce a protective response against P. brasiliensis. Presently, dexamethasone-treated BALB/c mice were intratracheally infected with P. brasiliensis Pb18 to establish the therapeutic efficacy of P10-pulsed DCs. Immunosuppressed and infected animals that received DCs had a reduction in their fungal burden, and this result was most pronounced in mice receiving DCs primed with P10. The efficacy of therapeutic DCs was significantly augmented by concomitant treatment with trimethoprim-sulfamethoxazole. Additionally, primedDCs with or without the antifungal drug induced a beneficial Th1-biased immune response and significantly reduced tissue damage. In conclusion, these studies with immunocompromised mice demonstrate that P10-pulsed DCs with or without concomitant antifungal drugs are potently effective in combating invasive PCM. These findings support further translational studies to validate the use of P10-primed DCs for PCM in immunocompetent and immunosuppressed hosts.Univ Sao Paulo, Trop Med Inst USP LIM53, Lab Med Mycol, Sao Paulo, BrazilUniv Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, BrazilAlbert Einstein Coll Med, Dept Med, Bronx, NY 10467 USAAlbert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USAUniv Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, BrazilWeb of ScienceFAPESPCNPqCAPESNIHFAPESP: 2016/08730-6CNPqCAPESNIH: AI52733NIH: AI1033142-21SNIH: AI124797Frontiers Media Sa2020-06-26T16:30:36Z2020-06-26T16:30:36Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion-application/pdfhttp://dx.doi.org/10.3389/fmicb.2017.01057Frontiers In Microbiology. Lausanne, v. 8, p. -, 2017.10.3389/fmicb.2017.01057WOS000403219300001.pdf1664-302Xhttps://repositorio.unifesp.br/handle/11600/53657WOS:000403219300001engFrontiers In MicrobiologyLausanneinfo:eu-repo/semantics/openAccessSilva, Leandro B. R.Dias, Lucas S.Rittner, Glauce M. G.Munoz, Julian E.Souza, Ana C. O.Nosanchuk, Joshua D.Travassos, Luiz R. [UNIFESP]Taborda, Carlos P.reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-11T01:46:43Zoai:repositorio.unifesp.br/:11600/53657Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-11T01:46:43Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis |
title |
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis |
spellingShingle |
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis Silva, Leandro B. R. Paracoccidioides brasiliensis paracoccidioidomycosis P10 adjuvants dendritic cells vaccine |
title_short |
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis |
title_full |
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis |
title_fullStr |
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis |
title_full_unstemmed |
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis |
title_sort |
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis |
author |
Silva, Leandro B. R. |
author_facet |
Silva, Leandro B. R. Dias, Lucas S. Rittner, Glauce M. G. Munoz, Julian E. Souza, Ana C. O. Nosanchuk, Joshua D. Travassos, Luiz R. [UNIFESP] Taborda, Carlos P. |
author_role |
author |
author2 |
Dias, Lucas S. Rittner, Glauce M. G. Munoz, Julian E. Souza, Ana C. O. Nosanchuk, Joshua D. Travassos, Luiz R. [UNIFESP] Taborda, Carlos P. |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Silva, Leandro B. R. Dias, Lucas S. Rittner, Glauce M. G. Munoz, Julian E. Souza, Ana C. O. Nosanchuk, Joshua D. Travassos, Luiz R. [UNIFESP] Taborda, Carlos P. |
dc.subject.por.fl_str_mv |
Paracoccidioides brasiliensis paracoccidioidomycosis P10 adjuvants dendritic cells vaccine |
topic |
Paracoccidioides brasiliensis paracoccidioidomycosis P10 adjuvants dendritic cells vaccine |
description |
Paracoccidioidomycosis (PCM) is an endemic systemic mycosis in Latin America, with the highest prevalence in Brazil, Colombia, and Venezuela. Fungi of the Paracoccidioides genus are etiologic agents of the disease. The 15 amino acid peptide P10 is derived from gp43, the main diagnostic antigen of Paracoccidioides brasiliensis. We previously reported that P10-pulsed dendritic cells (DCs) induce a protective response against P. brasiliensis. Presently, dexamethasone-treated BALB/c mice were intratracheally infected with P. brasiliensis Pb18 to establish the therapeutic efficacy of P10-pulsed DCs. Immunosuppressed and infected animals that received DCs had a reduction in their fungal burden, and this result was most pronounced in mice receiving DCs primed with P10. The efficacy of therapeutic DCs was significantly augmented by concomitant treatment with trimethoprim-sulfamethoxazole. Additionally, primedDCs with or without the antifungal drug induced a beneficial Th1-biased immune response and significantly reduced tissue damage. In conclusion, these studies with immunocompromised mice demonstrate that P10-pulsed DCs with or without concomitant antifungal drugs are potently effective in combating invasive PCM. These findings support further translational studies to validate the use of P10-primed DCs for PCM in immunocompetent and immunosuppressed hosts. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017 2020-06-26T16:30:36Z 2020-06-26T16:30:36Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.3389/fmicb.2017.01057 Frontiers In Microbiology. Lausanne, v. 8, p. -, 2017. 10.3389/fmicb.2017.01057 WOS000403219300001.pdf 1664-302X https://repositorio.unifesp.br/handle/11600/53657 WOS:000403219300001 |
url |
http://dx.doi.org/10.3389/fmicb.2017.01057 https://repositorio.unifesp.br/handle/11600/53657 |
identifier_str_mv |
Frontiers In Microbiology. Lausanne, v. 8, p. -, 2017. 10.3389/fmicb.2017.01057 WOS000403219300001.pdf 1664-302X WOS:000403219300001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Frontiers In Microbiology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
- application/pdf |
dc.coverage.none.fl_str_mv |
Lausanne |
dc.publisher.none.fl_str_mv |
Frontiers Media Sa |
publisher.none.fl_str_mv |
Frontiers Media Sa |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268344985976832 |